Skip to main content
Clinical Trials/CTRI/2014/08/004839
CTRI/2014/08/004839
Completed
未知

Retrospective analysis of patients who have received docetaxel, platinum, and 5-fluorouracil as induction chemotherapy for ca esophagus and gastroesophageal junction.

ot applicable0 sites31 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Patients of ca esophagus and gastroesophageal junction who have received docetaxel, platinum and 5-Fluorouracil as induction therapy
Sponsor
ot applicable
Enrollment
31
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • We will include patients who have received DCF induction chemotherapy for potentially resectable esophageal and GE junction carcinoma, from January 2010 to May 2014, whose data has been prospectively entered in a database that has been maintained in the medical oncology department at Tata Memorial Hospital.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials